. 2018 Sep 11;6:e5530. doi: 10.7717/peerj.5530

Table 2. CD133 expression and DNA mismatch repair (MMR) status.

The CD133 expression and MMR status as per size, TNM stage and differentiation of the colorectal carcinoma (n = 80).

Colorectal carcinoma characteristics		CD133										MMR status
		Immunoexpression			Score							pMMRn (%)	dMMR n (%)
		Pos n (%)	Neg n (%)	p	Units	p	Neg	Low n (%)	Intermediate n (%)	High n (%)	p			p
Size (cm)	0–5	35 (54.7)	4 (25.0)	0.071	9.5 ± 4.8	0.084	4 (25.0)	3 (37.5)	15 (60.0)	17 (54.8)	0.087	36 (54.5)	3 (21.4)	0.004*
	6–10	28 (43.8)	11 (68.8)		7.3 ± 6.0		11 (68.8)	4 (50.0)	10 40.0)	14 (45.2)		30 (45.5)	9 (64.3)
	11–15	1 (1.6)	1 (6.3)		2.0 ± 2.8		1 (6.3)	1 (12.5)	0 (0)	0 (0)		0 (0)	2 (14.3)
TNM Stage	I	7 (10.9)	0 (0)	0.250	11.4 ± 3.2	0.356	0 (0)	0 (0)	3 (12.0)	4 (12.9)	0.353	6 (9.1)	1 (7.1)	0.889
	II	19 (29.7)	8 (50.0)		7.2 ± 6.1		8 (50.0)	3 (37.5)	7 (28.0)	9 (29.0)		22 (33.3)	5 (35.7)
	III	32 (50.0)	8 (50.0)		8.5 ± 5.6		8 (50.0)	3 (37.5)	12 (48.0)	17 (54.8)		32 (48.5)	8 (57.1)
	IV	6 (9.4)	0 (0)		7.5 ± 3.8		0 (0)	2 (25.0)	3 (12.0)	1 (3.2)		6 (9.1)	0 (0)
Differentiation	Well	3 (4.7)	0 (0)	0.353	9.3 ± 3.1	0.123	0 (0)	0 (0)	2 (8.0)	1 (3.2)	0.078	3 (4.5)	0 (0)	0.008*
	Mod	51 (79.7)	11 (68.8)		8.8 ± 5.5		11 (68.8)	4 (50.0)	20 (80.0)	27 (87.1)		55 (83.3)	7 (50.0)
	Poor	10 (15.6)	5 (31.3)		5.5 ± 5.6		5 (31.3)	4 (50.0)	3 (12.0)	3 (9.7)		8 (12.1)	7 (50.0)

Notes.